2042 related articles for article (PubMed ID: 29133247)
21. Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.
Huang H; Li CQ; He DN; Ruan SM; Li MD; Cheng MQ; Lu MD; Kuang M; Wang W; Wang Y; Chen LD
Eur Radiol; 2023 Dec; 33(12):9336-9346. PubMed ID: 37405501
[TBL] [Abstract][Full Text] [Related]
22. Using new criteria to improve the differentiation between HCC and non-HCC malignancies: clinical practice and discussion in CEUS LI-RADS 2017.
Zeng D; Xu M; Liang JY; Cheng MQ; Huang H; Pan JM; Huang Y; Tong WJ; Xie XY; Lu MD; Kuang M; Chen LD; Hu HT; Wang W
Radiol Med; 2022 Jan; 127(1):1-10. PubMed ID: 34665430
[TBL] [Abstract][Full Text] [Related]
23. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
25. LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria.
Xian MF; Huang Y; Xie WX; Pan KM; Zeng D; Huang H; Li MD; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
AJR Am J Roentgenol; 2022 Jul; 219(1):76-85. PubMed ID: 34910538
[No Abstract] [Full Text] [Related]
26. Use of CEUS LI-RADS for the Accurate Diagnosis of Nodules in Patients at Risk for Hepatocellular Carcinoma: A Validation Study.
Makoyeva A; Kim TK; Jang HJ; Medellin A; Wilson SR
Radiol Imaging Cancer; 2020 Mar; 2(2):e190014. PubMed ID: 33778701
[TBL] [Abstract][Full Text] [Related]
27. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients.
Huang Z; Zhou P; Li S; Li K
Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338
[TBL] [Abstract][Full Text] [Related]
28. Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI?
Tan Z; Teoh WC; Wong KM; Wansaicheong GK; Sandrasegaran K
Clin Imaging; 2020 Jun; 62():63-68. PubMed ID: 32070868
[TBL] [Abstract][Full Text] [Related]
29. Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
Li L; Zheng W; Wang J; Han J; Guo Z; Hu Y; Li X; Zhou J
AJR Am J Roentgenol; 2022 Sep; 219(3):434-443. PubMed ID: 35441534
[No Abstract] [Full Text] [Related]
30. Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.
Sagrini E; Iavarone M; Stefanini F; Tovoli F; Vavassori S; Maggioni M; Renzulli M; Salvatore V; Stefanescu H; Colombo M; Bolondi L; Piscaglia F
United European Gastroenterol J; 2019 Feb; 7(1):69-77. PubMed ID: 30788118
[TBL] [Abstract][Full Text] [Related]
31. Intraindividual Comparison of Contrast-Enhanced Ultrasound Using Perfluorobutane With Modified Criteria Versus CT/MRI LI-RADS Version 2018 for Diagnosing HCC in High-Risk Patients.
Li L; Mao S; Wang J; Zheng W; Shen J; Clevert DA; Zhou J
AJR Am J Roentgenol; 2023 May; 220(5):682-691. PubMed ID: 36382914
[No Abstract] [Full Text] [Related]
32. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma.
Fowler KJ; Potretzke TA; Hope TA; Costa EA; Wilson SR
Abdom Radiol (NY); 2018 Jan; 43(1):149-157. PubMed ID: 28580538
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis.
Huang Z; Zhou P; Li S; Li K
Eur Radiol; 2022 Oct; 32(10):7146-7154. PubMed ID: 35639147
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
[TBL] [Abstract][Full Text] [Related]
35. Dynamic Contrast-Enhanced Ultrasonography Combined With LR-M Classification Criteria for Differentiating Malignant Liver Nodules at High Risk for Hepatocellular Carcinoma.
Qiu S; Ding J; Wang Y; Zhou H; Zhao L; Zhao L; Zhou Y; Fu Y; Jing X
Ultrasound Med Biol; 2024 Jul; 50(7):1028-1033. PubMed ID: 38632025
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.
Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V
J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B Infection.
Zheng W; Li Q; Zou XB; Wang JW; Han F; Li F; Huang LS; Li AH; Zhou JH
Radiology; 2020 Feb; 294(2):299-307. PubMed ID: 31769742
[TBL] [Abstract][Full Text] [Related]
39. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
Galassi M; Iavarone M; Rossi S; Bota S; Vavassori S; Rosa L; Leoni S; Venerandi L; Marinelli S; Sangiovanni A; Veronese L; Fraquelli M; Granito A; Golfieri R; Colombo M; Bolondi L; Piscaglia F
Liver Int; 2013 May; 33(5):771-9. PubMed ID: 23445369
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
Kim YY; An C; Kim S; Kim MJ
Eur Radiol; 2018 May; 28(5):2038-2046. PubMed ID: 29230525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
